C. Dabrowski

Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.

J. Subramanian, Y. Drew, J. Bosch-Barrera, 2022, Clinical lung cancer.

Analysis of Individual Human Trigeminal Ganglia for Latent Herpes Simplex Virus Type 1 and Varicella-Zoster Virus Nucleic Acids Using Real-Time PCR

Jessica A. Randall, R. Tal-Singer, R. Cohrs, 2000, Journal of Virology.

Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms.

K. King, J. Legos, Diptee A. Kulkarni, 2016, Pharmacogenomics.

Dostarlimab, an anti‐programmed death‐1 monoclonal antibody, does not cause QT prolongation in patients with solid tumours: A concentration‐QT analysis

Sharon M. Lu, M. Kuchimanchi, M. Melhem, 2023, British journal of clinical pharmacology.